Literature DB >> 6134921

Bronchoalveolar lavage in acquired immunodeficiency syndrome.

A Venet, G Dennewald, D Sandron, M Stern, F Jaubert, J Leibowitch.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6134921     DOI： 10.1016/s0140-6736(83)90041-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Value of bronchoalveolar lavage in the management of severe acute pneumonia and interstitial pneumonitis in the immunocompromised child.

Authors:  J de Blic; P McKelvie; M Le Bourgeois; S Blanche; M R Benoist; P Scheinmann
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

2.  Bronchoalveolar lavage in HIV infected patients with interstitial pneumonitis.

Authors:  J de Blic; S Blanche; C Danel; M Le Bourgeois; M Caniglia; P Scheinmann
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

3.  Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome.

Authors:  B S Bender; F A Auger; T C Quinn; R Redfield; J Gold; T M Folks
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Early experience and difficulties with bronchoalveolar lavage and transbronchial biopsy in the diagnosis of AIDS associated pneumonia in Britain.

Authors:  C R Swinburn; A L Pozniak; S Sutherland; R A Banks; A J Teall; N M Johnson
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

Review 5.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

6.  Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome.

Authors:  B S Bender; J F Bohnsack; S H Sourlis; M M Frank; T C Quinn
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection.

Authors:  R Zambello; L Trentin; R Benetti; A Cipriani; C Crivellaro; P Cadrobbi; C Agostini; G Semenzato
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.